mlsanityData to 14 Oct 2026

GLiNER-BioMed: A Suite of Efficient Models for Open Biomedical Named Entity Recognition

arXiv 2504.00676 ↗First posted 1 Apr 2025cs.CLcited by 3

Not on the map. Why?

Abstract (arXiv)

Biomedical named entity recognition (NER) presents unique challenges due to specialized vocabularies, the sheer volume of entities, and the continuous emergence of novel entities. Traditional NER models, constrained by fixed taxonomies and human annotations, struggle to generalize beyond predefined entity types. To address these issues, we introduce GLiNER-BioMed, a domain-adapted suite of Generalist and Lightweight Model for NER (GLiNER) models specifically tailored for biomedicine. In contrast to conventional approaches, GLiNER uses natural language labels to infer arbitrary entity types, enabling zero-shot recognition. Our approach first distills the annotation capabilities of large language models (LLMs) into a smaller, more efficient model, enabling the generation of high-coverage synthetic biomedical NER data. We subsequently train two GLiNER architectures, uni- and bi-encoder, at multiple scales to balance computational efficiency and recognition performance. Experiments on several biomedical datasets demonstrate that GLiNER-BioMed outperforms the state-of-the-art in both zero- and few-shot scenarios, achieving 5.96% improvement in F1-score over the strongest baseline (p-value < 0.001). Ablation studies highlight the effectiveness of our synthetic data generation strategy and emphasize the complementary benefits of synthetic biomedical pre-training combined with fine-tuning on general-domain annotations. All datasets, models, and training pipelines are publicly available at https://github.com/ds4dh/GLiNER-biomed.

Key facts. Cited by 3 papers in the map (data through 14 Oct 2026). Builds on 21 of its 65 references that are in the map. First posted on arXiv 1 Apr 2025.

Builds on

21 of 65 references.

References · 21

  1. 2018BERT: Pre-training of Deep Bidirectional Transformers for Language Understandingcited by 40,399
  2. 2024The Llama 3 Herd of Modelscited by 14,715
  3. 2021LoRA: Low-Rank Adaptation of Large Language Modelscited by 14,380
  4. 2019Sentence-BERT: Sentence Embeddings using Siamese BERT-Networkscited by 9,170
  5. 2023Efficient Memory Management for Large Language Model Serving with PagedAttentioncited by 5,944
  6. 2024Qwen2.5 Technical Reportcited by 4,942
  7. 2019BioBERT: a pre-trained biomedical language representation model for biomedical text miningcited by 1,947
  8. 2021DeBERTaV3: Improving DeBERTa using ELECTRA-Style Pre-Training with Gradient-Disentangled Embedding Sharingcited by 1,254
  9. 2024The FineWeb Datasets: Decanting the Web for the Finest Text Data at Scalecited by 1,160
  10. 2020Domain-Specific Language Model Pretraining for Biomedical Natural Language Processingcited by 1,009
  11. 2023C-Pack: Packed Resources For General Chinese Embeddingscited by 578
  12. 2022Unified Structure Generation for Universal Information Extractioncited by 221
9 more
  1. 2019A Unified MRC Framework for Named Entity Recognitioncited by 199
  2. 2023GLiNER: Generalist Model for Named Entity Recognition using Bidirectional Transformercited by 88
  3. 2022BioRED: A Rich Biomedical Relation Extraction Datasetcited by 85
  4. 2023UniversalNER: Targeted Distillation from Large Language Models for Open Named Entity Recognitioncited by 72
  5. 2024NuNER: Entity Recognition Encoder Pre-training via LLM-Annotated Datacited by 34
  6. 2022AIONER: All-in-one scheme-based biomedical named entity recognition using deep learningcited by 13
  7. 2024GLiNER multi-task: Generalist Lightweight Model for Various Information Extraction Taskscited by 8
  8. 2024Curating Grounded Synthetic Data with Global Perspectives for Equitable AIcited by 4
  9. 2023Efficient Joint Learning for Clinical Named Entity Recognition and Relation Extraction Using Fourier Networks: A Use Case in Adverse Drug Eventscited by 2

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2025: 1; 2026: 2.

3 papers.